Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GRANULES

  • FDA Approval
  • Aug. 21, 2024, 08:46 UTC
  • 54
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 21, 2024, 08:46 UTC
  • 52
  • 0 comments

FDA approve IFOSFAMIDE

Comment Full text

APOTEX CORP

  • FDA Approval
  • Aug. 21, 2024, 08:46 UTC
  • 42
  • 0 comments

FDA approve CUPRIC SULFATE

Comment Full text

TORRENT

  • FDA Approval
  • Aug. 21, 2024, 08:46 UTC
  • 55
  • 0 comments

FDA approve ANAGRELIDE HYDROCHLORIDE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Aug. 21, 2024, 08:46 UTC
  • 40
  • 0 comments

FDA approve LAZERTINIB

Comment Full text

HANGZHOU ZHONGMEI

  • FDA Approval
  • Aug. 21, 2024, 04:19 UTC
  • 52
  • 0 comments

FDA approve FONDAPARINUX SODIUM

Comment Full text

SUN PHARM

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 27
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 41
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 38
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

APOTEX

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 36
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text
  • Previous
  • 371
  • 372
  • 373
  • 374
  • 375
  • Next

Search

News categories

  • Technical Exchange News(11519)
  • Event(3471)
  • SEC News(216901)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137919)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin